scholarly journals Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Orofacial Pain

2013 ◽  
pp. S125-S134 ◽  
Author(s):  
J. FRICOVÁ ◽  
M. KLÍROVÁ ◽  
V. MASOPUST ◽  
T. NOVÁK ◽  
K. VÉREBOVÁ ◽  
...  

Repetitive transcranial magnetic stimulation (rTMS) is non-invasive neuromodulation method. We applied rTMS for the treatment of farmacoresistant chronic orofacial pain. We compared the effect of 10 Hz and 20 Hz stimulation. The study included 23 patients for 20 Hz stimulation and 36 patients for 10 Hz stimulation with pharmacotherapy resistant chronic facial pain aged 33-65 years with pain duration of at least 6 months. Monitoring of treatment effects was performed within 15 minutes of each rTMS application (days 1-5) and finally stimulation (active vs. sham coil). If compared with data with 10 Hz rTMS study (n=36) and with 20 Hz rTMS (n=23) trials using a parallel design. Only the results obtained in a series of five rTMS treatments in the first step (active n=24, sham n=12), that 20 Hz frequency rTMS using a higher intensity (95 % of motor threshold) to be equally effective relative to VAS (Visual analogue scale) and QST (quantitative sensory testing). In conclusions, the better results with the relief of orofacial pain were obtained with 20 Hz stimulation if compared with 10 Hz stimulation. It was proved with subjective (VAS) and objective evaluation (QST). rTMS can be used in the treatment of chronic intractable pain.

2019 ◽  
Vol 12 (3) ◽  
pp. 803-805 ◽  
Author(s):  
D.J.H.A. Henssen ◽  
W. Hoefsloot ◽  
P.S.M. Groenen ◽  
A.M. Van Cappellen van Walsum ◽  
E. Kurt ◽  
...  

Author(s):  
Raymond W. Lam

• Wake therapy, exercise and light therapy are non-invasive and clinically useful treatments.• Electroconvulsive therapy remains an effective, safe and well-tolerated treatment for patients with severe, psychotic or medication-resistant depression.• Repetitive transcranial magnetic stimulation is an emerging treatment with evidence for acute efficacy, but with limited data about long-term management....


2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Athina-Maria Aloizou ◽  
Georgia Pateraki ◽  
Konstantinos Anargyros ◽  
Vasileios Siokas ◽  
Christos Bakirtzis ◽  
...  

Abstract Multiple sclerosis (MS) is the most well-known autoimmune disorder of the central nervous system, and constitutes a major cause of disability, especially in young individuals. A wide array of pharmacological treatments is available, but they have often been proven to be ineffective in ameliorating disease symptomatology or slowing disease progress. As such, non-invasive and non-pharmacological techniques have been gaining more ground. Transcranial magnetic stimulation (TMS) utilizes the electric field generated by a magnetic coil to stimulate neurons and has been applied, usually paired with electroencephalography, to study the underlying pathophysiology of MS, and in repetitive trains, in the form of repetitive transcranial magnetic stimulation (rTMS), to induce long-lasting changes in neuronal circuits. In this review, we present the available literature on the application of TMS and rTMS in the context of MS, with an emphasis on its therapeutic potential on various clinical aspects, while also naming the ongoing trials, whose results are anticipated in the future.


1997 ◽  
Vol 31 (2) ◽  
pp. 264-272 ◽  
Author(s):  
Matthew T. K. Kirkcaldie ◽  
Saxby A. Pridmore ◽  
Alvaro Pascual-Leone

Objective: To provide an overview of the progress and prospects of transcranial magnetic stimulation as a psychiatric therapy for depression. Method: Published and unpublished studies of the usefulness of transcranial magnetic stimulation as a therapy for depression were assessed, and characterised in terms of a consistent measure of dosage. Additional information was obtained through correspondence, personal meetings and visits to facilities. Results: Transcranial magnetic stimulation, a means for inducing small regional currents in the brain, has been used in clinical neurology for some time, and can be used on conscious subjects with minimal side-effects. Early researchers noticed transient mood effects on people receiving this treatment, which prompted several inconclusive investigations of its effects on depressed patients. More recently, knowledge of functional abnormalities associated with depression has led to trials using repetitive transcranial magnetic stimulation to stimulate underactive left prefrontal regions, an approach which has produced short-term benefits for some subjects. The higher dosage delivered by high-frequency repetitive transcranial magnetic stimulation appears to produce greater benefits; scope exists for more conclusive studies based on extended treatment periods. Conclusions: Repetitive transcranial magnetic stimulation is a promising technology. The reviewed evidence indicates that it may be useful in the treatment of depression, and perhaps other disorders which are associated with regional hypometabolism. Should repetitive transcranial magnetic stimulation prove an effective, non-invasive, drug-free treatment for depression, a range of disorders could be similarly treatable.


2021 ◽  
Vol 15 ◽  
Author(s):  
Min Zhang ◽  
Runhua Wang ◽  
Xin Luo ◽  
Si Zhang ◽  
Xiaomei Zhong ◽  
...  

Major depressive disorder (MDD) is a substantial global public health problem in need of novel and effective treatment strategies. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and promising treatment for depression that has been approved by the U.S. Food and Drug Administration (FDA). However, the methodological weaknesses of existing work impairs the universal clinical use of rTMS. The variation of stimulated targets across the dorsolateral prefrontal cortex may account for most of the heterogeneity in the efficacy of rTMS. Many rTMS target location methods for MDD have been developed in recent decades. This review was conducted to assess this emerging field and to improve treatment outcomes in clinical practice.


PLoS ONE ◽  
2019 ◽  
Vol 14 (8) ◽  
pp. e0221110
Author(s):  
Natália R. Ferreira ◽  
Ygor N. Junqueira ◽  
Nathália B. Corrêa ◽  
Estevão O. Fonseca ◽  
Nathália B. M. Brito ◽  
...  

2021 ◽  
Vol 10 (22) ◽  
pp. 5422
Author(s):  
Alexa J. Denton ◽  
Ariel Finberg ◽  
Peter E. Ashman ◽  
Nathalie B. Bencie ◽  
Tricia Scaglione ◽  
...  

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive, neuromodulating technique for brain hyperexcitability disorders. The objective of this paper is to discuss the mechanism of action of rTMS as well as to investigate the literature involving the application of rTMS in the treatment of tinnitus. The reviewed aspects of the protocols included baseline evaluation, the total number of sessions, frequency and the total number of stimuli, the location of treatment, and the outcome measures. Even with heterogeneous protocols, most studies utilized validated tinnitus questionnaires as baseline and outcome measures. Low frequency (1 Hz) stimulation throughout 10 consecutive sessions was the most widely used frequency and treatment duration; however, there was no consensus on the total number of stimuli necessary to achieve significant results. The auditory cortex (AC) was the most targeted location, with most studies supporting changes in neural activity with multi-site stimulation to areas in the frontal cortex (FC), particularly the dorsolateral prefrontal cortex (DLPFC). The overall efficacy across most of the reviewed trials reveals positive statistically significant results. Though rTMS has proven to impact neuroplasticity at the microscopic and clinical level, further studies are warranted to demonstrate and support the clinical use of rTMS in tinnitus treatment with a standardized protocol.


Author(s):  
Laura Szucs-Bencze ◽  
Teodora Vekony ◽  
Orsolya Pesthy ◽  
Nikoletta Szabo ◽  
Zsigmond Tamas Kincses ◽  
...  

Sequence learning and statistical learning are key components of predictive processes and many cognitive, motor, and social skills. The Serial Reaction Time Task (SRTT) can measure this fundamental cognitive process in the visuomotor domain. Repetitive transcranial magnetic stimulation (rTMS) is an increasingly used non-invasive brain stimulation method that can help us to determine the functional role of a given brain region. In this literature review, we systematically analyzed the eligible records (n = 17) that sought to modulate the performance on the SRTT with rTMS. The purpose of the analysis was to determine the effects of the following factors on SRTT performance: (1) stimulated brain areas, (2) rTMS protocols, (3) stimulated hemisphere, (4) timing of the stimulation, (5) SRTT sequence properties, and (6) other methodological features. We found that the two most promising target areas are the primary motor cortex (M1) and the dorsolateral prefrontal cortex (DLPFC). Low-frequency protocols over the M1 usually weakened performance, but the results are less consistent for the DLPFC. Our analysis of these six factors could help design future studies to modulate sequence learning by non-invasive brain stimulation.


Sign in / Sign up

Export Citation Format

Share Document